Taiwan · Delayed Price · Currency is TWD Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 3.23 billion. The enterprise value is 4.23 billion.
| Market Cap | 3.23B |
| Enterprise Value | 4.23B |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Mar 27, 2025 |
Share Statistics
Synbio Tech has 34.48 million shares outstanding. The number of shares has increased by 3.83% in one year.
| Current Share Class | 34.48M |
| Shares Outstanding | 34.48M |
| Shares Change (YoY) | +3.83% |
| Shares Change (QoQ) | +5.65% |
| Owned by Insiders (%) | 22.19% |
| Owned by Institutions (%) | n/a |
| Float | 16.40M |
Valuation Ratios
The trailing PE ratio is 19.63 and the forward PE ratio is 12.72.
| PE Ratio | 19.63 |
| Forward PE | 12.72 |
| PS Ratio | 3.23 |
| PB Ratio | 2.54 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 19.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.16, with an EV/FCF ratio of -11.70.
| EV / Earnings | 27.19 |
| EV / Sales | 4.23 |
| EV / EBITDA | 16.16 |
| EV / EBIT | 22.52 |
| EV / FCF | -11.70 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.03.
| Current Ratio | 1.46 |
| Quick Ratio | 0.72 |
| Debt / Equity | 1.03 |
| Debt / EBITDA | 4.98 |
| Debt / FCF | -3.60 |
| Interest Coverage | 26.77 |
Financial Efficiency
Return on equity (ROE) is 13.35% and return on invested capital (ROIC) is 5.09%.
| Return on Equity (ROE) | 13.35% |
| Return on Assets (ROA) | 4.60% |
| Return on Invested Capital (ROIC) | 5.09% |
| Return on Capital Employed (ROCE) | 8.09% |
| Revenue Per Employee | 10.88M |
| Profits Per Employee | 1.69M |
| Employee Count | 92 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.14 |
Taxes
In the past 12 months, Synbio Tech has paid 37.56 million in taxes.
| Income Tax | 37.56M |
| Effective Tax Rate | 19.44% |
Stock Price Statistics
The stock price has increased by +18.76% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +18.76% |
| 50-Day Moving Average | 105.81 |
| 200-Day Moving Average | 100.37 |
| Relative Strength Index (RSI) | 37.88 |
| Average Volume (20 Days) | 156,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 1.00 billion and earned 155.61 million in profits. Earnings per share was 4.77.
| Revenue | 1.00B |
| Gross Profit | 540.63M |
| Operating Income | 187.91M |
| Pretax Income | 193.16M |
| Net Income | 155.61M |
| EBITDA | 261.79M |
| EBIT | 187.91M |
| Earnings Per Share (EPS) | 4.77 |
Balance Sheet
The company has 302.33 million in cash and 1.30 billion in debt, giving a net cash position of -1.00 billion or -29.04 per share.
| Cash & Cash Equivalents | 302.33M |
| Total Debt | 1.30B |
| Net Cash | -1.00B |
| Net Cash Per Share | -29.04 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 36.79 |
| Working Capital | 243.66M |
Cash Flow
In the last 12 months, operating cash flow was 167.03 million and capital expenditures -528.72 million, giving a free cash flow of -361.68 million.
| Operating Cash Flow | 167.03M |
| Capital Expenditures | -528.72M |
| Free Cash Flow | -361.68M |
| FCF Per Share | -10.49 |
Margins
Gross margin is 54.03%, with operating and profit margins of 18.78% and 15.55%.
| Gross Margin | 54.03% |
| Operating Margin | 18.78% |
| Pretax Margin | 19.31% |
| Profit Margin | 15.55% |
| EBITDA Margin | 26.16% |
| EBIT Margin | 18.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.74%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 3.74% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 70.52% |
| Buyback Yield | -3.83% |
| Shareholder Yield | -0.14% |
| Earnings Yield | 4.82% |
| FCF Yield | -11.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 2.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 4 |